危重症患者-话题@MedSci

#危重症患者#

24篇内容 | 2489人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1526127, encodeId=a764152612ef5, content=<a href='/topic/show?id=a08b36e6548' target=_blank style='color:#2F92EE;'>#危重症患者#</a>, objectTitle=【专题】危重症患者诊疗指南干货，速速围观！, objectType=article, longId=99909, objectId=90fc99909ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90fc99909ea, replyNumber=0, likeNumber=76, createdTime=2017-05-29, rootId=0, userName=liuquan, userId=bfbf11697948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90fc99909ea, moduleTitle=【专题】危重症患者诊疗指南干货，速速围观！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90fc99909ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1526126, encodeId=847015261263e, content=<a href='/topic/show?id=a08b36e6548' target=_blank style='color:#2F92EE;'>#危重症患者#</a>, objectTitle=Crit Care：液体负平衡危重症患者液体摄入与死亡率的关系如何？, objectType=article, longId=98694, objectId=bf28986945c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf28986945c, replyNumber=0, likeNumber=69, createdTime=2017-05-15, rootId=0, userName=liuquan, userId=bfbf11697948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf28986945c, moduleTitle=Crit Care：液体负平衡危重症患者液体摄入与死亡率的关系如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf28986945c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1526125, encodeId=a4d21526125ad, content=<a href='/topic/show?id=a08b36e6548' target=_blank style='color:#2F92EE;'>#危重症患者#</a>, objectTitle=JAMA Inter Med：免疫功能危重症患者巨细胞病毒再激活的抗病毒治疗, objectType=article, longId=97684, objectId=7bb89e684e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bb89e684e6, replyNumber=0, likeNumber=75, createdTime=2017-05-03, rootId=0, userName=liuquan, userId=bfbf11697948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bb89e684e6, moduleTitle=JAMA Inter Med：免疫功能危重症患者巨细胞病毒再激活的抗病毒治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bb89e684e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1526124, encodeId=c8df152612436, content=<a href='/topic/show?id=a08b36e6548' target=_blank style='color:#2F92EE;'>#危重症患者#</a>, objectTitle=谷氨酰胺在危重症患者中临床应用的专家推荐意见（节录）, objectType=article, longId=85214, objectId=cce08521471, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cce08521471, replyNumber=0, likeNumber=87, createdTime=2016-12-24, rootId=0, userName=liuquan, userId=bfbf11697948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cce08521471, moduleTitle=谷氨酰胺在危重症患者中临床应用的专家推荐意见（节录）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cce08521471)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1526123, encodeId=52d415261231a, content=<a href='/topic/show?id=a08b36e6548' target=_blank style='color:#2F92EE;'>#危重症患者#</a>, objectTitle=2016ATS/ACCP临床实践指南：危重症患者机械通气撤机发布, objectType=article, longId=80868, objectId=93d3808688f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93d3808688f, replyNumber=0, likeNumber=46, createdTime=2016-10-26, rootId=0, userName=liuquan, userId=bfbf11697948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93d3808688f, moduleTitle=2016ATS/ACCP临床实践指南：危重症患者机械通气撤机发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93d3808688f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1526122, encodeId=f2d515261224f, content=<a href='/topic/show?id=a08b36e6548' target=_blank style='color:#2F92EE;'>#危重症患者#</a>, objectTitle=AJRCCM：他汀类可降低危重症患者发生谵妄的风险, objectType=article, longId=32307, objectId=ffec3230e18, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffec3230e18, replyNumber=0, likeNumber=75, createdTime=2014-03-26, rootId=0, userName=liuquan, userId=bfbf11697948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffec3230e18, moduleTitle=AJRCCM：他汀类可降低危重症患者发生谵妄的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffec3230e18)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

危重症患者

2020-05-29

liuquan (审核中...)

前往app查看评论内容

#危重症患者#

【专题】危重症患者诊疗指南干货，速速围观！

2017-05-29

liuquan (审核中...)

前往app查看评论内容

#危重症患者#

Crit Care：液体负平衡危重症患者液体摄入与死亡率的关系如何？

2017-05-15

liuquan (审核中...)

前往app查看评论内容

#危重症患者#

JAMA Inter Med：免疫功能危重症患者巨细胞病毒再激活的抗病毒治疗

2017-05-03

liuquan (审核中...)

前往app查看评论内容

#危重症患者#

谷氨酰胺在危重症患者中临床应用的专家推荐意见（节录）

2016-12-24

liuquan (审核中...)

前往app查看评论内容

#危重症患者#

2016ATS/ACCP临床实践指南：危重症患者机械通气撤机发布

2016-10-26

liuquan (审核中...)

前往app查看评论内容

#危重症患者#

AJRCCM：他汀类可降低危重症患者发生谵妄的风险

2014-03-26

科室
- - 订阅+
  - 更多科室
工具
服务